Dermatophagoides farinae -specific IgG responses in atopic dogs undergoing allergen-specific immunotherapy with aqueous vaccines

Veterinary Dermatology

Volumn 19, Issue 4, 2008, Pages 215-220

  Hill, Peter B ^a   Hou, Chia Chun ^a   Griffin, Craig E ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Animal Dermatology Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACARI; CANIS FAMILIARIS; CAPRA HIRCUS; DERMATOPHAGOIDES FARINAE;

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN G; VACCINE;

ACTIVE IMMUNIZATION; ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; DOG; DOG DISEASE; IMMUNOLOGY; METABOLISM;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; IMMUNOGLOBULIN G; IMMUNOTHERAPY, ACTIVE; VACCINES;

EID: 58149378953     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2008.00682.x     Document Type: Article

References (36)

1. Hill PB, DeBoer DJ. The ACVD task force on canine atopic dermatitis (IV): environmental allergens. Veterinary Immunology and Immunopathology 2001; 81: 169-86.
2. Hill PB, Olivry T. The ACVD task force on canine atopic dermatitis (V): biology and role of inflammatory cells in cutaneous allergic reactions. Veterinary Immunology and Immunopathology 2001; 81: 187-98.
3. Scott DW, Miller WH, Griffin CE. Canine atopic dermatitis. In: Scott DW, Miller WH, Griffin CE, eds. Muller and Kirk's Small Animal Dermatology. Philadelphia, PA: W.B. Saunders, 2001: 574-601.
4. Olivry T, Mueller RS. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis. Veterinary Dermatology 2003; 14: 121-46.
5. Griffin CE, Hillier A. The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy. Veterinary Immunology and Immunopathology 2001; 81: 363-83.
6. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. Journal of Allergy and Clinical Immunology 1998; 102: 558-62.
7. Wittich FW. Spontaneous allergy (atopy) in the lower animal. Journal of Allergy 1941; 12: 247-51.
8. Mueller RS, Bettenay SV. Long-term immunotherapy of 146 dogs with atopic dermatitis ? a retrospective study. Australian Veterinary Practitioner 1996; 26: 128-32.
9. Nesbitt GH. Canine allergic inhalant dermatitis: a review of 230 cases. Journal of the American Veterinary Medical Association 1978; 172: 55-60.
10. Scott KV, White SD, Rosychuk RAW. A retrospective study of hyposensitization in atopic dogs in a flea-scarce environment. In: Ihrke PJ, Mason IS, White SD, eds. Advances in Veterinary Dermatology, Vol. 2. Oxford, UK: Pergamon Press, 1993: 79-87.
11. Willemse A, van den Brom WE, Rijnberk A. Effect of hyposensitization on atopic dermatitis in dogs. Journal of the American Veterinary Medical Association 1984; 184: 1277-80.
12. Zur G, White SD, Ihrke PJ, Kass PH, Toebe N. Canine atopic dermatitis: a retrospective study of 169 cases examined at the University of California, Davis, 1992-98. Part II. Response to hyposensitization. Veterinary Dermatology 2002; 13: 103-11.
13. Nuttall TJ, Thoday KL, van den Broek AH, Jackson HA, Sture GH, Halliwell RE. Retrospective survey of allergen immunotherapy in canine atopy. Veterinary Record 1998; 143: 139-42.
14. Rueff F, Wolf H, Schnitker J, Ring J, Przybilla B. Specific immunotherapy in honeybee venom allergy: a comparative study using aqueous and aluminium hydroxide adsorbed preparations. Allergy 2004; 59: 589-95.
15. Shim JY, Kim BS, Cho SH, Min KU, Hong SJ. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clinical and Experimental Allergy 2003; 33: 52-7.
16. Kimura I, Tanizaki Y, Goda Y, Komagoe H, Kitani H. Decrease in reactivity of basophils by immunotherapy with housedust extract. Clinical Allergy 1985; 15: 1-7.
17. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. Journal of Immunology 1995; 154: 4187-94.
18. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clinical and Experimental Allergy 1995; 25: 828-38.
19. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. Journal of Experimental Medicine 1993; 178: 2123-30.
20. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. Journal of Clinical Investigation 1998; 102: 98-106.
21. Bellinghausen I, Metz G, Enk AH, Christmann S, Knop J, Saloga J. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. European Journal of Immunology 1997; 27: 1131-9.
22. Francis JN, Till SJ, Durham SR. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy. Journal of Allergy and Clinical Immunology 2003; 111: 1255-61.
23. McHugh SM, Lavelle B, Kemeny DM, Patel S, Ewan PW. A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses. Journal of Allergy and Clinical Immunology 1990; 86: 521-31.
24. Muller U, Helbling A, Bischof M. Predictive value of venomspecific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 1989; 44: 412-8.
25. Fraser MA, McNeil PE, Gettinby G. Examination of serum total IgG1 concentration in atopic and non-atopic dogs. Journal of Small Animal Practice 2004; 45: 186-90.
26. Hites MJ, Kleinbeck ML, Loker JL, Lee KW. Effect of Immunotherapy on the serum concentrations of allergen-specific IgG antibodies in dog sera. Veterinary Immunology and Immunopathology 1989; 22: 39-51.
27. Hou CC, Nuttall TJ, Day MJ, Hill PB. Dermatophagoides farinaespecific IgG subclass responses in atopic dogs undergoing allergen-specific immunotherapy. In: Hillier A, Foster AP, Kwochka KW, eds. Advances in Veterinary Dermatology, Vol. 5. Oxford, UK: Blackwell Publishing, 2005: 70-81.
28. Hou CC, Pemberton A, Nuttall TJ, Hill PB. IgG responses to antigens from Dermatophagoides farinae in healthy and atopic dogs. Veterinary Immunology and Immunopathology 2005; 106: 121-8.
29. Hou CC, Day MJ, Nuttall TJ, Hill PB. Evaluation of IgG subclass responses against Dermatophagoides farinae allergens in healthy and atopic dogs. Veterinary Dermatology 2006; 17: 103-10.
30. DeBoer DJ, Hillier A. The ACVD task force on canine atopic dermatitis (XV): fundamental concepts in clinical diagnosis. Veterinary Immunology and Immunopathology 2001; 81: 271-6.
31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
32. McCall C, Hunter S, Stedman K et al. Characterization and cloning of a major high molecular weight house dust mite allergen (Der f 15) for dogs. Veterinary Immunology and Immunopathology 2001; 78: 231-47.
33. Noli C, Bernadina WE, Willemse T. The significance of reactions to purified fractions of Dermatophagoides pteronyssinus and Dermatophagoides farinae in canine atopic dermatitis. Veterinary Immunology and Immunopathology 1996; 52: 147-57.
34. Nuttall TJ, Lamb JR, Hill PB. Characterisation of major and minor Dermatophagoides allergens in canine atopic dermatitis. Research in Veterinary Science 2001; 71: 51-7.
35. Yunginger JW. Immunotherapy of allergic disease. In: Lockey RF, Bukantz SC, eds. Principle of Immunology and Allergy. New York: W.B. Saunders, 1987: 101-10.
36. Hardy CL, Rolland JM, O'Hehir RE. Blocking antibodies in allergen immunotherapy: the Yin and Yang. Clinical and Experimental Allergy 2004; 34: 510-2.